Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Early Morning Call: Traders cautious after US earnings, First Republic Bank

Video poster image

APAC equity markets traded mostly lower on Wednesday, following a negative session in the US. In Australia, consumer price index rose 7%, in the first quarter, from 7.8% in the previous three months. For March alone, the CPI rose 6.3% on the year, down from 6.8% in February. Crucially, the RBA trimmed mean CPI, a measure of inflation favoured by the Australian central bank, rose 1.2% in the March quarter, after 1.7% the previous quarter, and lower than the 1.4% anticipated by economists. Futures now imply only a 9% chance of a quarter-point rise in the 3.6% cash rate. The RBA is due to decide on rates next Tuesday.

In Germany, GfK consumer confidence rose more than expected in May, to -25.7, after -29.3 in April. Economist expected a rise to -27.9.

Elsewhere on the equity markets, GSK is the first of a series of pharma group to report earnings this week. GSK published an adjusted operating profit of £2.09Bln, up 9%, helped by sales of its blockbuster shingles vaccine Shingrix. GSK confirmed its full-year guidance.

Standard Chartered posted a 25% increase in underlying pretax profit to $1.7Bln, beating analyst estimates. The bank benefited from rising interest rates and increased trading. This was the largest single-quarter profit since the start of 2014, as credit impairment remained low at just $26 million for the quarter, down from $198 million a year earlier. Standard Chartered said it planned to return in excess of $5Bln to shareholders by 2024.

Elsewhere in Europe, look out for Roche shares in Zurich. The pharmaceutical group unveiled a 7% drop in sales in the first quarter on falling demand for its COVID-19 therapies and diagnostics kits. Also watch out for Danone in France. the group posted better-then-expected sales for the first quarter and raised its 2023 sales growth outlook.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.